Proline sulfonamide derivatives as orexin receptor antagonists
US9211279B2 · kind B2 · utility
3Cited by
9References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 5, 2015 |
| Grant date | Dec 15, 2015 |
| Priority date | — |
| Expiry date | Mar 5, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to (S)-proline sulfonamide compounds of formula (I)wherein R1 and R2 are as described in the description, or pharmaceutically acceptable salts thereof, for use in the prevention or treatment of diseases or disorders related to the orexin system. The present invention also relates to the use of (S)-proline sulfonamide compounds of formula (II) as pharmaceuticals, to pharmaceutical compositions comprising compounds of formula (II), and especially their use in the prevention or treatment of diseases or disorders related to the orexin system.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.